BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioCapital

  Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane

  This scientific study was a collaborative effort of scientists from the NJCBM at Rutgers, The State University of New Jersey in the laboratory of Professor Joachim Kohn and Osiris Therapeutics.

  October 24, 2017

   · 

  5 min read
• Business

  Prescient Healthcare Group Continues to Build Its Foundation for Success

  Prescient Healthcare Group, a global product strategy and decision support consultancy, announces the recent appointments of Nick Edwards and Nader Naeymi-Rad to the Board of Directors, further strengthening its foundation for continued success.

  October 24, 2017

   · 

  2 min read
• Drug Development

  Innovation Pharmaceuticals Provides Development Update on Brilacidin for Inflammatory Bowel Disease

  Following the successful completion of its Phase 2 trial, the Company is making plans to advance the clinical development of Brilacidin-IBD.

  October 24, 2017

   · 

  7 min read
• Business

  AMPAC Fine Chemicals Announces Expansion of Their Executive Team

  AMPAC Fine Chemicals (AFC) is pleased to announce the addition of two new members to their executive team.

  October 24, 2017

   · 

  1 min read
• Lone Star Bio

  CellRight Technologies to Participate in World’s Largest Spine Exhibition

  Tissue Regenix Group plc, the UK based regenerative medical devices company announces subsidiary CellRight Technologies will be participating in The North American Spine Society annual meeting - NASS 2017, being held in Orlando, Florida, October 25-28 2017.

  October 24, 2017

   · 

  3 min read
• Drug Manufacturers and the New FDA Drug Listing Rules - a Primer From Data Conversion Laboratory

  Data Conversion Laboratory (DCL) is offering a free webinar on October 26 at 1:00pm ET to explain the new FDA drug listing rules, which will be affecting all U.S. drug listings.

  October 24, 2017

   · 

  2 min read
• Drug Development

  Dimerix Receives Ethics Committee Approval in Australia for Pharmacokinetic Trial of New Extended Release Formulation

  Dimerix Limited, is pleased to announce that it has received ethics committee approval for a study in healthy volunteers to determine the pharmacokinetic properties of the novel extended release propagermanium tablet to be used in the Company’s DMX-200 Phase 2b trial in Chronic Kidney Disease.

  October 24, 2017

   · 

  3 min read
• Drug Development

  BerGenBio Announces Start of Phase II Trial Assessing Selective AXL Inhibitor BGB324 in Combination With KEYTRUDA for Patients With Advanced Lung Cancer

  BerGenBio announces that the first patient has been dosed in a Phase II trial evaluating the Company’s lead product BGB324 in combination with KEYTRUDA (pembrolizumab).

  October 24, 2017

   · 

  4 min read
• Business

  Ligand to Report Third Quarter 2017 Results on November 9th

  Ligand Pharmaceuticals Incorporated announced today that it plans to report third quarter 2017 financial results after market close on November 9, 2017 and to provide additional commentary during its Analyst Day.

  October 24, 2017

   · 

  2 min read
• IX Biopharma Secures European Patent For Waferix Drug Delivery Technology

  Homegrown specialty pharmaceutical company iX Biopharma is pleased to announce that it has been granted a European patent (no. 2493457) for its WaferiX drug delivery technology.

  October 24, 2017

   · 

  2 min read